Cargando…

Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1

The co-inhibitory immune checkpoint interaction between programmed cell death-protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) serves to regulate T-cell activation, promoting self-tolerance. Over-expression of PD-L1 is a mechanism through which tumour cells can evade detection by the immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Kayleigh, Waters, Lorna C., Kelly, Geoff, Muskett, Frederick W., Carr, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510113/
https://www.ncbi.nlm.nih.gov/pubmed/35675028
http://dx.doi.org/10.1007/s12104-022-10092-5
_version_ 1784797381270700032
author Walker, Kayleigh
Waters, Lorna C.
Kelly, Geoff
Muskett, Frederick W.
Carr, Mark D.
author_facet Walker, Kayleigh
Waters, Lorna C.
Kelly, Geoff
Muskett, Frederick W.
Carr, Mark D.
author_sort Walker, Kayleigh
collection PubMed
description The co-inhibitory immune checkpoint interaction between programmed cell death-protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) serves to regulate T-cell activation, promoting self-tolerance. Over-expression of PD-L1 is a mechanism through which tumour cells can evade detection by the immune system. Several therapeutic antibodies targeting PD-L1 or PD-1 have been approved for the treatment of a variety of cancers, however, the discovery and development of small-molecule inhibitors of PD-L1 remains a challenge. Here we report comprehensive sequence-specific backbone resonance assignments ((1)H, (13)C, and (15)N) obtained for the N-terminal IgV-like domain of PD-L1 (D1) and the full two domain extracellular region (D1D2). These NMR assignments will serve as a useful tool in the discovery of small-molecule therapeutics targeting PD-L1 and in the characterisation of functional interactions with other protein partners, such as CD80.
format Online
Article
Text
id pubmed-9510113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-95101132022-09-27 Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1 Walker, Kayleigh Waters, Lorna C. Kelly, Geoff Muskett, Frederick W. Carr, Mark D. Biomol NMR Assign Article The co-inhibitory immune checkpoint interaction between programmed cell death-protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) serves to regulate T-cell activation, promoting self-tolerance. Over-expression of PD-L1 is a mechanism through which tumour cells can evade detection by the immune system. Several therapeutic antibodies targeting PD-L1 or PD-1 have been approved for the treatment of a variety of cancers, however, the discovery and development of small-molecule inhibitors of PD-L1 remains a challenge. Here we report comprehensive sequence-specific backbone resonance assignments ((1)H, (13)C, and (15)N) obtained for the N-terminal IgV-like domain of PD-L1 (D1) and the full two domain extracellular region (D1D2). These NMR assignments will serve as a useful tool in the discovery of small-molecule therapeutics targeting PD-L1 and in the characterisation of functional interactions with other protein partners, such as CD80. Springer Netherlands 2022-06-08 2022 /pmc/articles/PMC9510113/ /pubmed/35675028 http://dx.doi.org/10.1007/s12104-022-10092-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Walker, Kayleigh
Waters, Lorna C.
Kelly, Geoff
Muskett, Frederick W.
Carr, Mark D.
Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1
title Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1
title_full Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1
title_fullStr Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1
title_full_unstemmed Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1
title_short Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1
title_sort sequence-specific (1)h, (13)c and (15)n backbone nmr assignments for the n-terminal igv-like domain (d1) and full extracellular region (d1d2) of pd-l1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510113/
https://www.ncbi.nlm.nih.gov/pubmed/35675028
http://dx.doi.org/10.1007/s12104-022-10092-5
work_keys_str_mv AT walkerkayleigh sequencespecific1h13cand15nbackbonenmrassignmentsforthenterminaligvlikedomaind1andfullextracellularregiond1d2ofpdl1
AT waterslornac sequencespecific1h13cand15nbackbonenmrassignmentsforthenterminaligvlikedomaind1andfullextracellularregiond1d2ofpdl1
AT kellygeoff sequencespecific1h13cand15nbackbonenmrassignmentsforthenterminaligvlikedomaind1andfullextracellularregiond1d2ofpdl1
AT muskettfrederickw sequencespecific1h13cand15nbackbonenmrassignmentsforthenterminaligvlikedomaind1andfullextracellularregiond1d2ofpdl1
AT carrmarkd sequencespecific1h13cand15nbackbonenmrassignmentsforthenterminaligvlikedomaind1andfullextracellularregiond1d2ofpdl1